IHH has launched an internal Innovation Portal to recognise and facilitate sharing of innovation projects, connect staff with relevant and interesting digital health companies, and provide access to relevant research and market reports. Highlights of this portal:
1. Innovation Portfolio Companies - IHH is a strategic investor in early stage innovative digital health companies. Staff can take a look at what our portfolio companies can offer and how we are working with them.
2. Proprietary Start-Up Database - Enable IHH staff to look for relevant technologies or solutions.
3. Featured Innovations – Spotlights innovation projects across our markets.
We hope this portal will help our staff and various functions enhance IHH’s clinical, operational and service capabilities to deliver even better patient care. Through Innovation, we can achieve and deliver “Care. For Good”.
If you are a digital health company interested in connecting with IHH, you can email us at [email protected].
Related Stories
-(13).png?sfvrsn=74979ce6_1)
Charting What’s Next: How IHH Malaysia is Transforming Together
At the recent IHH Malaysia CEO Town Hall, leaders and staff came together to reaffirm a shared commitment to transforming healthcare through value-based care, sustainable practices, and support for our people.
Empowering Young Professionals: IHH Singapore Launches NexGen Committee
IHH Healthcare Singapore has established the NexGen Committee, a dedicated initiative aimed at enhancing workplace experiences and career growth for young professionals within the organisation.
Transformation Takes Centerstage at the Parkway Laboratories Staff Town Hall
Transformation was the heartbeat of the day at Parkway Laboratories' 2025 staff town hall on 11 April 2025.
Fortis Hospital Shalimar Bagh Champions Gender Equality with Walkathon
Advancing Treatment for Pulmonary Arterial Hypertension: An Approach with Sotatercept
A development in Pulmonary Arterial Hypertension (PAH) treatment took place at Mount Elizabeth Hospital, Singapore, where a patient received Sotatercept — a therapy that offers additional possibilities for managing this complex condition. This reflects ongoing progress in cardiology and pulmonary hypertension care.
